Detalhe da pesquisa
1.
Zanubrutinib or Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia.
N Engl J Med;
388(4): 319-332, 2023 01 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36511784
2.
Plain language summary of zanubrutinib or ibrutinib in chronic lymphocytic leukemia that is resistant to treatment or has come back after treatment.
Future Oncol;
20(12): 717-726, 2024 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38088119
3.
Zanubrutinib Versus Ibrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma: Interim Analysis of a Randomized Phase III Trial.
J Clin Oncol;
41(5): 1035-1045, 2023 02 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36395435
4.
Flow Cytometric Evaluation of Double/Triple Hit Lymphoma.
Oncol Res;
23(3): 137-46, 2016.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26931436
5.
Intensive chemotherapy in patients aged 70 years or older newly diagnosed with acute myeloid leukemia.
Oncol Res;
22(2): 85-92, 2015.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25706395